Driscoll Martin J 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Apr 30, 2019
Insider Transaction Report
Form 4
Driscoll Martin J
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2019-04-30$7.31/sh+5,000$36,550→ 65,400 total - Purchase
Common Stock
2019-04-30$7.36/sh+5,000$36,800→ 70,400 total